A phase III trial of docetaxel/carboplatin versus mitomycin C/ifosfamide/cisplatin (MIC) or mitomycin C/vinblastine/cisplatin (MVP) in patients with advanced non-small-cell lung cancer: a randomised multicentre trial of the British Thoracic Oncology Group (BTOG1)
Titel:
A phase III trial of docetaxel/carboplatin versus mitomycin C/ifosfamide/cisplatin (MIC) or mitomycin C/vinblastine/cisplatin (MVP) in patients with advanced non-small-cell lung cancer: a randomised multicentre trial of the British Thoracic Oncology Group (BTOG1)
Auteur:
Booton, R. Lorigan, P. Anderson, H. Baka, S. Ashcroft, L. Nicolson, M. O'Brien, M. Dunlop, D. O'Byrne, K. Laurence, V. Snee, M. Dark, G. Thatcher, N.